| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |